Loading clinical trials...
Loading clinical trials...
Factors and Experiences Associated with Unscheduled Hospital Readmission After Crenel Lateral Interbody Fusion
The goal of this observational study is to learn about the readmission related to Crenel Lateral Interbody Fusion (CLIF). The main question it aims to answer is: What are the risk factors for readmission after CLIF surgery?
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China
Start Date
April 3, 2024
Primary Completion Date
July 25, 2024
Completion Date
August 2, 2024
Last Updated
October 1, 2024
100
ACTUAL participants
Crenel Lateral Interbody Fusion
PROCEDURE
Crenel lateral interbody fusion plus second stage surgery
PROCEDURE
Lead Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
NCT06202443
NCT07026552
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05452694